Skip to content
  • About
  • Contact
  • Contribute
  • Book
  • Careers
  • Podcast
  • Recommended
  • Speaking
  • All
  • Physician
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
  • Video
    • All
    • Physician
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • Video
    • About
    • Contact
    • Contribute
    • Book
    • Careers
    • Podcast
    • Recommended
    • Speaking

How can we improve the quality of medications?

J. Leonard Lichtenfeld, MD
Meds
September 30, 2020
133 Shares
Share
Tweet
Share

Do you know what it’s like to sit in a meeting and learn that something you hold close as a fundamental principle is probably not as fundamentally true as you thought?

That’s the way I felt earlier this week while attending a meeting on the quality of pharmaceuticals, sponsored by the Food and Drug Administration and Duke University’s Margolis Center for Health Policy.

The meeting—a recording of which is available online—brought together thought leaders from the FDA, Duke, hospital systems, pharmaceutical companies, patient advocates, and others, including the American Cancer Society to discuss issues surrounding the quality assurance of the medicines we rely on every day.

Some of the information was unsettling:

  • The quality of medicines produced in the United States and Europe ranks high. Not so much for those produced in other parts of the world, including China and India
  • One pharma executive made the public statement that he would not take medicines manufactured in India or China—if he was even able to determine the country of manufacture, a determination which itself is problematic
  • A hospital system pharmacist recounted their experience with a drug used to fight the rejection of organ transplants that apparently stopped working on their patients. On further investigation, they found the drug they were using was defective
  • A physician recounted their experience with a patient who had advanced heart failure, which was well controlled. Suddenly, their condition deteriorated, and they had to be admitted to the hospital. Control of heart failure was achieved, only to recur when the patient went home. This scenario repeated itself several times, until they discovered that the pharmacy that dispensed the medicine to the patient to use at home had a change in manufacturer. Put back on the original prescription; the patient once again did well.
  • Another participant recounted that the problems recently encountered with some antihypertensive drugs that led to massive recalls were due to the fact that the manufacturer decided to use a chemical derived from rocket fuel—yes, rocket fuel—that led to contamination with nitrosamines, which are known carcinogens. And that it took months for the knowledge to work its way through the system and lead to a recall.

For me, this is personal.

During the early part of my training and career as a physician, I experienced the arguments for and against the use of generic drugs. As I progressed in my career, I used generic medicines whenever possible in the care of my patients. They were far less expensive, and they worked. Today most of the medicines used in this country are generic. Every day I take generic medicines, and so far so good—except for those recalls mentioned above.

Now I am not so certain based on the comments made at this meeting, especially for drugs manufactured in some foreign countries. It appears that their commitment to quality simply isn’t to the level that most of us expect, and that’s a problem.

A couple of months ago, a physician colleague of mine raised the question of drug quality—focusing on generics—and said in his opinion that the country of manufacture should be on the bottle label. Honestly, I didn’t see the need at that time.

Fast forward, and I can say that a considerable amount of the discussion during the meeting was exactly on that topic: how can we tell where the drug was manufactured, since the country of origin may influence quality? And that is complicated by the fact that our medicines may have components made in several countries, brought together in one place where they are combined further complicating their origin and other factors that could be problematic such as temperature during transportation.

Compound that with the fact that it is very difficult for a pharmacist, let alone a doctor or patient, to determine the source of the medicine, who really made all the ingredients, and what manufacture lot it came from.  Trying to offer a patient who is stable on chronic medications the same medicine from the same manufacturer refill after refill is out the window if the supplier changes. The pharmacist has no way to control the source of many of the medications they dispense to patients. Usually, it is someone else making the decision on which supplier or manufacturer they will be using for that medicine at any point in time.

And then there is the inevitable question: If we really want better assurance that our pills meet quality standards, who is going to pay for it?

It was clear from the discussions that cost is the driving factor for many of the medicines we take. Cost to the insurer, cost to the patient, cost to the health system. However, what’s the cost of bad medicines? Who pays for that? Well, all of us, to be honest.

Let’s abandon the thought that we don’t care about quality and won’t pay for it.

Decades ago, auto manufacturers in the United States were forced to improve the quality of the cars they produced because autos from Japan and Germany were notably better. Over time, consumers voted with their feet, and quality was forced to improve. And today, as noted in the current issue of Consumer Reports, the costs of cars (and our insurance) is increasing because more systems are built in to increase safety, with the hope over time that those costs will stabilize or go down because of improved systems and fewer accidents and serious injuries. Society made a choice that the investment in quality and safety is worth it when it comes to automobiles.

There is certainly a lot of complexity in solving this problem. The FDA is committed to fixing it, however, resources are limited, and the solutions are complicated. Even finding the information to assess pharmaceutical quality can be very difficult. Part of the problem is that we need those resources and commitments to get this fixed. That’s a point that everyone in the room agreed on. How we get there won’t be easy. It’s clear we need to get started somewhere.

What about holding some of the companies who have repeated poor quality reports accountable? Should drug distributors and pharmacy benefit managers—who know about these issues—turn their eyes elsewhere when they know this is a problem? Should insurers accept this as the status quo and not figure out how to pay for quality medications even if it costs a bit more (which by the way they theoretically could recover if fewer people had their blood pressure poorly controlled because of ineffective medications)?

So, my colleague was right: There is a problem, and to him, I say publicly “mea culpa.” And to you, I say this is a problem that demands attention. Right now, it is the stuff of experts in the private and non-profit sectors and government agencies. Maybe its time that we as consumers and health professionals increase our awareness, band together, and demand a solution.

J. Leonard Lichtenfeld is deputy chief medical officer, American Cancer Society. He blogs at Dr. Len’s Cancer Blog.

Image credit: Shutterstock.com 

Prev

My mother has Alzheimer’s: a caregiver's story [PODCAST]

September 29, 2020 Kevin 0
…
Next

Talking politics in the exam room

September 30, 2020 Kevin 5
…

Tagged as: Medications

Post navigation

< Previous Post
My mother has Alzheimer’s: a caregiver's story [PODCAST]
Next Post >
Talking politics in the exam room

More by J. Leonard Lichtenfeld, MD

  • Why won’t unproven COVID treatments go away?

    J. Leonard Lichtenfeld, MD
  • Sunscreens: The balancing act between safety and cancer prevention

    J. Leonard Lichtenfeld, MD
  • It’s time we get the technology working for the patients, and not make their lives more difficult

    J. Leonard Lichtenfeld, MD

Related Posts

  • The ritual of taking medications: the pill wheel

    Fery Pashang, PharmD
  • Do quality metrics really improve patient care?

    Fred N. Pelzman, MD
  • The folly of using money to improve health care quality

    Robert Pearl, MD
  • Quality measures have gotten ahead of the science of quality measurement

    Peter Ubel, MD
  • Tips to help you afford medications

    Roy Benaroch, MD
  • The double-edged power of the medications we prescribe

    Hans Duvefelt, MD

More in Meds

  • The real cause of America’s opioid crisis: Doctors are not to blame

    Richard A. Lawhern, PhD
  • Can personalized medicine live up to its hype in health care?

    Ketan Desai, MD, PhD
  • The effects of the nationwide stimulant shortage on a private psychiatry practice

    Christine Tran-Boynes, DO
  • Why North American medical cannabis can’t compete globally

    Michael Sassano
  • How were we duped and what can we do about the opioid overdose crisis?

    Ronald A. Zent, MD
  • Caught in the middle: How health insurance companies influence cancer drug selection

    Paul Pender, MD
  • Most Popular

  • Past Week

    • The real cause of America’s opioid crisis: Doctors are not to blame

      Richard A. Lawhern, PhD | Meds
    • Healing the damaged nurse-physician dynamic

      Angel J. Mena, MD and Ali Morin, MSN, RN | Policy
    • The struggle to fill emergency medicine residency spots: Exploring the factors behind the unfilled match

      Katrina Gipson, MD, MPH | Physician
    • Breaking the stigma: Addressing the struggles of physicians

      Jean Antonucci, MD | Physician
    • Beyond the disease: the power of empathy in health care

      Nana Dadzie Ghansah, MD | Physician
    • Deaths of despair: an urgent call for a collective response to the crisis in U.S. life expectancy

      Mohammed Umer Waris, MD | Policy
  • Past 6 Months

    • The hidden dangers of the Nebraska Heartbeat Act

      Meghan Sheehan, MD | Policy
    • The real cause of America’s opioid crisis: Doctors are not to blame

      Richard A. Lawhern, PhD | Meds
    • Nobody wants this job. Should physicians stick around?

      Katie Klingberg, MD | Physician
    • The fight for reproductive health: Why medication abortion matters

      Catherine Hennessey, MD | Physician
    • The vital importance of climate change education in medical schools

      Helen Kim, MD | Policy
    • Resetting the doctor-patient relationship: Navigating the challenges of modern primary care

      Jeffrey H. Millstein, MD | Physician
  • Recent Posts

    • The pros and cons of using ChatGPT for your health care needs

      Liudmila Schafer, MD | Tech
    • Dr. Glaucomflecken for president!

      Aaron Morgenstein, MD & Amy Bissada, DO & Corinne Sundar Rao, MD | Physician
    • What is driving physicians to the edge of despair?

      Edward T. Creagan, MD | Physician
    • Do residents deserve the title of physician?

      Anonymous | Physician
    • A new era of collaboration between AI and health care professionals

      Harvey Castro, MD, MBA | Tech
    • When an MBA degree meets medicine: an eye-opening experience

      Arthur Lazarus, MD, MBA | Physician

Subscribe to KevinMD and never miss a story!

Get free updates delivered free to your inbox.


Find jobs at
Careers by KevinMD.com

Search thousands of physician, PA, NP, and CRNA jobs now.

Learn more

Leave a Comment

Founded in 2004 by Kevin Pho, MD, KevinMD.com is the web’s leading platform where physicians, advanced practitioners, nurses, medical students, and patients share their insight and tell their stories.

Social

  • Like on Facebook
  • Follow on Twitter
  • Connect on Linkedin
  • Subscribe on Youtube
  • Instagram

CME Spotlights

From MedPage Today

Latest News

  • How Did Pulse Oximeters Perform in Black Kids?
  • Coffee and Heart Function; Ionizing Radiation and CVD
  • Health Inequity Should Be Labeled as a 'Never Event'
  • Healing the Damaged Nurse-Physician Dynamic
  • Doc Moms, Mind the Gap -- $3M Earning Difference by Sex

Meeting Coverage

  • Switch to IL-23 Blocker Yields Deep Responses in Recalcitrant Plaque Psoriasis
  • Biomarkers of Response With Enfortumab Vedotin in Advanced Urothelial Cancer
  • At-Home Topical Therapy for Molluscum Contagiosum Gets High Marks
  • Outlook for Itchy Prurigo Nodularis Continues to Improve With IL-31 Antagonist
  • AAAAI President Shares Highlights From the 2023 Meeting
  • Most Popular

  • Past Week

    • The real cause of America’s opioid crisis: Doctors are not to blame

      Richard A. Lawhern, PhD | Meds
    • Healing the damaged nurse-physician dynamic

      Angel J. Mena, MD and Ali Morin, MSN, RN | Policy
    • The struggle to fill emergency medicine residency spots: Exploring the factors behind the unfilled match

      Katrina Gipson, MD, MPH | Physician
    • Breaking the stigma: Addressing the struggles of physicians

      Jean Antonucci, MD | Physician
    • Beyond the disease: the power of empathy in health care

      Nana Dadzie Ghansah, MD | Physician
    • Deaths of despair: an urgent call for a collective response to the crisis in U.S. life expectancy

      Mohammed Umer Waris, MD | Policy
  • Past 6 Months

    • The hidden dangers of the Nebraska Heartbeat Act

      Meghan Sheehan, MD | Policy
    • The real cause of America’s opioid crisis: Doctors are not to blame

      Richard A. Lawhern, PhD | Meds
    • Nobody wants this job. Should physicians stick around?

      Katie Klingberg, MD | Physician
    • The fight for reproductive health: Why medication abortion matters

      Catherine Hennessey, MD | Physician
    • The vital importance of climate change education in medical schools

      Helen Kim, MD | Policy
    • Resetting the doctor-patient relationship: Navigating the challenges of modern primary care

      Jeffrey H. Millstein, MD | Physician
  • Recent Posts

    • The pros and cons of using ChatGPT for your health care needs

      Liudmila Schafer, MD | Tech
    • Dr. Glaucomflecken for president!

      Aaron Morgenstein, MD & Amy Bissada, DO & Corinne Sundar Rao, MD | Physician
    • What is driving physicians to the edge of despair?

      Edward T. Creagan, MD | Physician
    • Do residents deserve the title of physician?

      Anonymous | Physician
    • A new era of collaboration between AI and health care professionals

      Harvey Castro, MD, MBA | Tech
    • When an MBA degree meets medicine: an eye-opening experience

      Arthur Lazarus, MD, MBA | Physician

MedPage Today Professional

An Everyday Health Property Medpage Today iMedicalApps
  • Terms of Use | Disclaimer
  • Privacy Policy
  • DMCA Policy
All Content © KevinMD, LLC
Site by Outthink Group

Leave a Comment

Comments are moderated before they are published. Please read the comment policy.

Loading Comments...